this quarterly is so vital for the share price. If cash burn is high again then I cant see it rising much. If cashburn has reduced (increased revenue, same/reduced expenditure) then we should see some positive movement. I think no one doubts the long term success of cardiocel but are gunshy into buying a share when a cap raising may come. If they cap raise for the vaccine then no one will care as we may have hit the motherload by then.
this quarterly is so vital for the share price. If cash burn is...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.90 |
Change
1.050(9.68%) |
Mkt cap ! $251.5M | |||
| Open | High | Low | Value | Volume |
| $11.00 | $11.90 | $10.85 | $504.4K | 45.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $11.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.90 | 99 | 1 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |